T

Thor Medical ASA
OSE:TRMED

Watchlist Manager
Thor Medical ASA
OSE:TRMED
Watchlist
Price: 2.835 NOK 10.74% Market Closed
Market Cap: 665.8m NOK
Have any thoughts about
Thor Medical ASA?
Write Note

EV/FCFF
Enterprise Value to FCFF

-23.1
Current
-2.2
Median
3.6
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-23.1
=
Enterprise Value
737.7m NOK
/
FCFF
-27.6m NOK
All Countries
Close
Market Cap EV/FCFF
NO
Thor Medical ASA
OSE:TRMED
665.8m NOK -23.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 926.9
US
Abbvie Inc
NYSE:ABBV
325.5B USD 24.1
US
Amgen Inc
NASDAQ:AMGN
150.4B USD 31.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.9B USD -83.8
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 11
US
Epizyme Inc
F:EPE
94.1B EUR -473.4
AU
CSL Ltd
ASX:CSL
135.7B AUD 64.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.7B USD 23.1
US
Seagen Inc
F:SGT
39.3B EUR -57.1
NL
argenx SE
XBRU:ARGX
34.6B EUR -102.1
 
NO
T
Thor Medical ASA
OSE:TRMED
Average EV/FCFF: 30.9
Negative Multiple: -23.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 926.9
US
Abbvie Inc
NYSE:ABBV
24.1
US
Amgen Inc
NASDAQ:AMGN
31.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -83.8
US
Gilead Sciences Inc
NASDAQ:GILD
11
US
E
Epizyme Inc
F:EPE
Negative Multiple: -473.4
AU
CSL Ltd
ASX:CSL
64.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
23.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -102.1

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More